These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19729972)

  • 21. Anti-brain autoantibodies in the serum of schizophrenic patients: a case-control study.
    Margari F; Petruzzelli MG; Mianulli R; Toto M; Pastore A; Bizzaro N; Tampoia M
    Psychiatry Res; 2013 Dec; 210(3):800-5. PubMed ID: 24103908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex differences, season of birth and platelet 5-HT levels in schizophrenic patients.
    Mück-Seler D; Pivac N; Jakovljević M
    J Neural Transm (Vienna); 1999; 106(3-4):337-47. PubMed ID: 10392542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased plasma levels of thioredoxin-1 in patients with first episode psychosis and long-term schizophrenia.
    Owe-Larsson B; Ekdahl K; Edbom T; Osby U; Karlsson H; Lundberg C; Lundberg M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1117-21. PubMed ID: 21457743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
    Bakalova RA; Hadzhimitova V; Ribarov S
    Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia.
    Dror N; Klein E; Karry R; Sheinkman A; Kirsh Z; Mazor M; Tzukerman M; Ben-Shachar D
    Mol Psychiatry; 2002; 7(9):995-1001. PubMed ID: 12399953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative stress in blood platelets from schizophrenic patients.
    Dietrich-Muszalska A; Olas B; Rabe-Jablonska J
    Platelets; 2005 Nov; 16(7):386-91. PubMed ID: 16236599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cold agglutinin autoantibodies in psychiatric patients: their relation to diagnosis and pharmacological treatment.
    Spivak B; Radwan M; Brandon J; Molcho A; Ohring R; Tyano S; Weizman A
    Am J Psychiatry; 1991 Feb; 148(2):244-7. PubMed ID: 1899010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile.
    Pazvantoglu O; Selek S; Okay IT; Sengul C; Karabekiroglu K; Dilbaz N; Erel O
    Psychiatry Clin Neurosci; 2009 Oct; 63(5):693-700. PubMed ID: 19788631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of patients with schizophrenia, obsessive-compulsive disorder, and schizophrenia with accompanying obsessive-compulsive symptoms].
    Güleç G; Güneş E; Yenilmez C
    Turk Psikiyatri Derg; 2008; 19(3):247-56. PubMed ID: 18791877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue-binding factor in schizophrenic sera: a clinical and genetic study.
    Baron M; Stern M; Anavi R; Witz IP
    Biol Psychiatry; 1977 Apr; 12(2):199-219. PubMed ID: 870093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The neurotropic and autoimmune activity of the serum of patients with psychoses of old age and patients with schizophrenia].
    Solntseva EI; Kushner SG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(8):1228-31. PubMed ID: 1217418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intensity of negative symptoms, working memory and executive functions disturbances in schizophrenic patients in partial remission period].
    Hintze B; Borkowska A
    Psychiatr Pol; 2011; 45(4):457-67. PubMed ID: 22232973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High homocysteine serum levels in young male schizophrenia and bipolar patients and in an animal model.
    Levine J; Sela BA; Osher Y; Belmaker RH
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Sep; 29(7):1181-91. PubMed ID: 16115716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy.
    De Bellis A; Sansone D; Coronella C; Conte M; Iorio S; Perrino S; Battaglia M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):24-9. PubMed ID: 15638866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: a preliminary study.
    Albayrak Y; Ünsal C; Beyazyüz M; Ünal A; Kuloğlu M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():144-9. PubMed ID: 23657077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A conformational epitope which detects autoantibodies from schizophrenic patients.
    Deckmann M; Mamillapalli R; Schechtman L; Shinitzky M
    Clin Chim Acta; 2002 Aug; 322(1-2):91-8. PubMed ID: 12104086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relationship between insight and self-reported quality of life among shizophrenic patients].
    Aghababian V; Auquier P; Baumstarck-Barrau K; Lançon C
    Encephale; 2011 Jun; 37(3):162-71. PubMed ID: 21703431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased serum levels of inflammatory markers in chronic institutionalized patients with schizophrenia.
    Coelho FM; Reis HJ; Nicolato R; Romano-Silva MA; Teixeira MM; Bauer ME; Teixeira AL
    Neuroimmunomodulation; 2008; 15(2):140-4. PubMed ID: 18679053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.